🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and effectiveness of ...
Status
Completed
Location
Swedish American Neuro and Headache Center
Start Date
2014-08
Trial ID
NCT02176018
Treatments Being Tested
Objectives of the study are to evaluate the safety, tolerability, and effic...
Status
Completed
Location
St. Joseph's Hospital and Medical Center
Start Date
2007-12
Trial ID
NCT00573443
Nuedexta is FDA approved for the treatment of pseudobulbar affect in ALS pa...
Status
Completed
Location
Phil Smith Neuroscience Institute at Holy Cross Hospital
Start Date
2019-07-25
Trial ID
NCT03883581
Treatments Being Tested
The objectives of the study are to evaluate the safety, tolerability and ef...
Status
Completed
Location
Multiple Locations
Start Date
2012-08-13
Trial ID
NCT01584440
Treatments Being Tested
The objectives of the study are to evaluate the safety, tolerability, and e...
Status
Completed
Location
Multiple Locations
Start Date
2013-02
Trial ID
NCT01799941
Treatments Being Tested
The objectives of the study are to evaluate the safety, tolerability, and e...
Status
Completed
Location
North Central Neurology Associates PC
Start Date
2011-09-08
Trial ID
NCT01324232
Treatments Being Tested
This study will be conducted to evaluate the relative bioavailability, phar...
Status
Completed
Location
Vince & Associates Clinical Research
Start Date
2017-11-28
Trial ID
NCT03381664
Treatments Being Tested
The primary objective of this study is to test the hypothesis that Nuedexta...
Status
Terminated
Location
Barrow Neurological Institute
Start Date
2012-08-28
Trial ID
NCT01832350
Treatments Being Tested
Primary: Demonstrate reduced frequency and intensity of maladaptive behavio...
Status
Completed
Location
Sutter Pediatric Neurology
Start Date
2012-01-24
Trial ID
NCT01630811
6 month study of NUEDEXTA ® (Dextromethorphan Hydrobromide and Quinidine Su...
Status
Terminated
Location
Multiple Locations
Start Date
2015-09
Trial ID
NCT02496039
Treatments Being Tested